Arrow Generics, a Watson Company, launches Pioglitazone Tablets.
Posted on 25th Jan 2012
Arrow Generics, a Watson Company, today announced the launch of Pioglitazone Tablets in the UK following MA approval from the MHRA. Pioglitazone is available in strengths of 15mg, 30mg and 45mg tablets in packs of 28 in Arrow livery.
Pioglitazone is a generic version of Takeda's Actos® and is indicated in the treatment of Type II Diabetes.
Please see the below link that will take you to the Pioglitazone Educational page where you will find further information relating to the product.
If you require further information please contact us via the web page.